We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LABL
2001
DELISTED
Multi-Color Corp
LABL
| $634K | ﹤0.01% |
8,295
+46
| +0.6% | +$3.02K |
|
|
NXTM
2002
DELISTED
NxStage Medical Inc.
NXTM
| $633K | ﹤0.01% |
40,142
-1,181
| -3% | -$18.9K |
|
|
LOXO
2003
DELISTED
Loxo Oncology, Inc
LOXO
| $630K | ﹤0.01% |
36,038
-325
| -0.9% | -$6.36K |
|
2004
Banner Corp
BANR
$2.38B
| $629K | ﹤0.01% |
13,166
-576
| -4% | -$26.8K |
|
|
TUMI
2005
DELISTED
TUMI HLDGS INC COM
TUMI
| $629K | ﹤0.01% |
35,711
-1,266
| -3% | -$24.9K |
|
2006
ScottsMiracle-Gro
SMG
$4.09B
| $627K | ﹤0.01% |
10,304
+3,724
| +57% | +$230K |
|
2007
Crane NXT
CXT
$2.99B
| $625K | ﹤0.01% |
38,625
-848,591
| -96% | -$15.6M |
|
|
ABAX
2008
DELISTED
Abaxis Inc
ABAX
| $625K | ﹤0.01% |
14,219
-470
| -3% | -$23.1K |
|
2009
Insight Enterprises
NSIT
$3.85B
| $624K | ﹤0.01% |
24,143
-1,279
| -5% | -$33.8K |
|
|
PGNX
2010
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $624K | ﹤0.01% |
109,039
-2,981
| -3% | -$22.9K |
|
2011
Landstar System
LSTR
$6.03B
| $623K | ﹤0.01% |
9,811
+3,368
| +52% | +$230K |
|
2012
Federated Hermes
FHI
$4.56B
| $622K | ﹤0.01% |
21,520
-133,999
| -86% | -$4.29M |
|
2013
IPG Photonics
IPGP
$3.4B
| $622K | ﹤0.01% |
8,187
+2,887
| +54% | +$245K |
|
|
UPL
2014
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $622K | ﹤0.01% |
97,267
-3,131
| -3% | -$24.8K |
|
|
ALJ
2015
DELISTED
Alon USA Energy Inc
ALJ
| $622K | ﹤0.01% |
34,430
+14,740
| +75% | +$279K |
|
2016
Greif
GEF
$4.95B
| $621K | ﹤0.01% |
19,472
-771
| -4% | -$25.1K |
|
|
CNSL
2017
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $620K | ﹤0.01% |
32,193
-633
| -2% | -$12.6K |
|
|
BEL
2018
DELISTED
Belmond Ltd.
BEL
| $620K | ﹤0.01% |
61,358
-612,825
| -91% | -$7.04M |
|
2019
Advanced Drainage Systems
WMS
$10.6B
| $619K | ﹤0.01% |
21,409
+726
| +4% | +$21K |
|
|
NP
2020
DELISTED
Neenah, Inc. Common Stock
NP
| $619K | ﹤0.01% |
10,613
-464
| -4% | -$27.2K |
|
|
CDMO
2021
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $618K | ﹤0.01% |
86,567
+21,022
| +32% | +$175K |
|
2022
American Homes 4 Rent
AMH
$12.1B
| $617K | ﹤0.01% |
38,374
+16,331
| +74% | +$262K |
|
|
VSI
2023
DELISTED
Vitamin Shoppe Inc.
VSI
| $617K | ﹤0.01% |
18,891
-817
| -4% | -$29.1K |
|
|
BPFH
2024
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $616K | ﹤0.01% |
52,651
-1,643
| -3% | -$20.3K |
|
|
PDM
2025
Piedmont Realty Trust
PDM
$1.24B
| $615K | ﹤0.01% |
34,358
+12,443
| +57% | +$222K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.